First Radiobiological Characterization of Skin and Bone Cells from A Patient Suffering from the PI3KCA-Related Overgrowth Spectrum (PROS) Syndrome. Archives of Clinical and Medical Case Reports, v. 4, n. 6, p. 1052–1066, 6 Nov.2020.